| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Liu Jun | CEO and President, Director, 10%+ Owner | C/O CURANEX PHARMACEUTICALS INC, 2 JERICHO PLAZA SUITE 101 B, JERICHO | /s/ Jun Liu | 02 Sep 2025 | 0002083812 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | CURX | Common Stock | 7,076,160 | 25 Aug 2025 | Direct | ||||||
| holding | CURX | Common Stock | 3,248,400 | 25 Aug 2025 | See footnote | F1 | |||||
| holding | CURX | Common Stock | 912,600 | 25 Aug 2025 | See footnote | F2 | |||||
| holding | CURX | Series A Preferred Stock | 490,000 | 25 Aug 2025 | Direct | ||||||
| holding | CURX | Series A Preferred Stock | 200,000 | 25 Aug 2025 | See footnote | F3 |
| Id | Content |
|---|---|
| F1 | These shares of common stock are beneficially owned by the Reporting Person through Dian Ying Jing, his wife, who holds these shares directly. By virtue of this relationship, the Reporting Person may be deemed to share beneficial ownership of the securities held by record by Dian Ying Jing. |
| F2 | These shares of common stock are beneficially owned by the Reporting Person through Doublewin Developer LLC, an entity in which Dian Ying Jing, his wife, has sole voting and investment power. By virtue of this relationship, the Reporting Person may be deemed to share beneficial ownership of the securities held of record by Doublewin Developer LLC. |
| F3 | These shares of Series A Preferred Stock are beneficially owned by the Reporting Person through Dian Ying Jing, his wife, who holds these shares directly. By virtue of this relationship, the Reporting Person may be deemed to share beneficial ownership of the securities held of record by Dian Ying Jing. |